Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses.

Item

http://www.wikidata.org/entity/Q35868890

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Pneumococcal polysaccharide va ...... s functional immune responses.

@ast

Pneumococcal polysaccharide va ...... s functional immune responses.

@en

type

Item

label

Pneumococcal polysaccharide va ...... s functional immune responses.

@ast

Pneumococcal polysaccharide va ...... s functional immune responses.

@en

prefLabel

Pneumococcal polysaccharide va ...... s functional immune responses.

@ast

Pneumococcal polysaccharide va ...... s functional immune responses.

@en

P1476

Pneumococcal polysaccharide va ...... es functional immune responses

@en

P2093

Anne Balloch

http://www.w3.org/2001/XMLSchema#string

Edward K Mulholland

http://www.w3.org/2001/XMLSchema#string

Fiona M Russell

http://www.w3.org/2001/XMLSchema#string

Jisheng Lin

http://www.w3.org/2001/XMLSchema#string

Mimi L K Tang

http://www.w3.org/2001/XMLSchema#string

Paul V Licciardi

http://www.w3.org/2001/XMLSchema#string

Robert L Burton

http://www.w3.org/2001/XMLSchema#string

P2860

Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B

Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity.

Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.

Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine.

Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines.

Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.

P304

794-800.e2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2011.11.043

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

Moon H. Nahm

P577

2012-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221806272

http://www.w3.org/2001/XMLSchema#string

P698

22305678

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

3318993

http://www.w3.org/2001/XMLSchema#string